Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials-Reference-Cited by-同舟云学术

Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials

Published:2005-11 Issue:18 Volume:112 Page:2833-2839
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Mauri Laura¹,Orav E. John¹,Candia Susana C.¹,Cutlip Donald E.¹,Kuntz Richard E.¹

Affiliation:

1. From the Brigham and Women’s Hospital (L.M., E.J.O., S.C.C., R.E.K.), Beth Israel Deaconess Hospital (D.E.C.), Harvard Clinical Research Institute (L.M., D.E.C., R.E.K.), and Harvard Medical School (L.M., E.J.O., D.E.C., R.E.K.), Boston, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference54 articles.

1. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy

2. Usefulness of a cobalt chromium coronary stent alloy

3. Neurohormonal Activation in Congestive Heart Failure and the Role of Vasopressin

4. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

5. A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early effect of different bifurcation techniques on left ventricular mechanics in elective percutaneous coronary intervention;The Egyptian Heart Journal;2024-07-02

2. Clinical Phenotyping with an Outcomes-driven Mixture of Experts for Patient Matching and Risk Estimation;ACM Transactions on Computing for Healthcare;2023-10-13

3. Safe and effective profile of the VSTENT bioresorbable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions: a prospective, cohort, multicenter study;Cardiovascular Diagnosis and Therapy;2023-06

4. Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases;Frontiers in Cardiovascular Medicine;2022-06-22

5. Nine‐month angiographic and 2‐year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus‐eluting COMBO dual‐therapy stent versus a polymer‐free sirolimus‐eluting stent in Chinese patients;Catheterization and Cardiovascular Interventions;2021-02-19